Comparative effectiveness of teclistamab versus real-world physician's choice of therapy (RWPC) for patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Krishnan, A.; Nooka, A.; Chari, A.; Garfall, A. L.; Martin, T.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; Ammann, E.; Chastain, K.; Parekh, T.; Marshall, A.; Slavcev, M.; Usmani, S. Z. |
| Abstract Title: | Comparative effectiveness of teclistamab versus real-world physician's choice of therapy (RWPC) for patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | ISPOR Europe 2023 |
| Journal Title: | Value in Health |
| Volume: | 26 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2023 Nov 12-15 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2023-12-01 |
| Start Page: | S37 |
| Language: | English |
| ACCESSION: | WOS:001137279500155 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2023.09.201 |
| Notes: | Meeting Abstract: CO129 -- Source: Wos |
